reports. Billing records were examined to determine revenue and costs per surgery. Contribution margin (CM), defined as hospital revenue minus variable cost based on actual resources used, was calculated for each case. Data analysis of consulting cases, primary plastic surgery cases, and all other cases was performed using R Statistical Software (Foundation for Statistical Computing, Vienna, Austria).
RESULTS:
During the study period, there were 696 cases with a primary non-plastic surgeon who required a consulting reconstructive surgeon. There were 993 primary plastic surgery cases, and 21,146 nonconsult cases performed by other surgical specialties that were identified for comparison. The specialties most commonly requesting reconstructive assistance were orthopedic surgery (n = 139), neurosurgery (n = 124), breast/surgical oncology (n = 86), and cardiothoracic surgery (n = 71). Average net revenue per case was greatest for the consult group, $94,557 per case, versus $73,824 per case for primary plastic surgeries and $60,758 per case for the non-consult comparison group. Average CM for plastic surgery consult cases was $39,326. This CM was significantly greater when compared to primary plastic surgery cases ($25,779; P < 0.05), and to all other nonconsult cases ($24,789; P < 0.05).
DISCUSSION:
Plastic surgeons provide frequent and valuable operative assistance to other surgical services. Cases that require plastic surgery consultation generate more revenue than those performed by either the plastic surgery department alone or any other department. Furthermore, these cases demonstrate a significantly higher CM, which is a measure of overall profit generation for the hospital. This financial impact is poorly captured by current hospital tracking systems, which categorize only by primary surgical specialty. The specific skill set of plastic surgeons is thus an undervalued resource for both patient care and hospital financial well-being. By understanding the economic contribution of reconstructive surgery at the institutional level, resource allocation can be better tailored to support future growth of these departments.
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PURPOSE: The goal of this study is to evaluate the differences and similarities between near-infrared spectroscopy (NIRS) with laser Doppler flowmetry (LDF) in adjunct monitoring of free flaps. Their efficacy, recorded data trend, and device characteristics will be compared.
METHODS AND MATERIALS:
After institutional review board approval at Banner MD Anderson Cancer Center, the charts of 60 consecutive free flap patients over 2-year period were reviewed. There were 6 bilateral deep inferior epigastric cases and 2 cases where each flap had 3 and 2 monitored components, respectively. The choice in using either adjunct monitor, ViOptix T.Ox (ViOptix Inc., Fremont, CA) or Laser Doppler (LD) Periflux 5000 (Perimed AB, Järfälla, Sweden), was not standardized, except that the ViOptix probe (larger) was never chosen for intraoral flaps. Total of 67 monitoring events occurred: 38 with LDF on 37 flaps of 35 patients (head/neck 29, breast 7, lower extremity 1); 29 with ViOptix on 25 patients (head/neck 12, breast 15, upper extremity 1, and lower extremity 1).
RESULTS:
Of the 37 free flaps monitored by LDF, there were 2 take backs because of diminishing values: LD numbers dropped from 17.4 to 4.4 in case of fibula hematoma and from 14.7 to 4.7 in case of venous thrombosis of serratus to leg. Of the 28 flaps monitored with ViOptix, there were 2 re-explorations: ViOptix numbers dropped from 46% to 20s for the deep inferior epigastric pedicle stretch and from 32% to 28% for perforator compression hours after thoracodorsal-scapular-chimeric flap to cheek. All 4 flaps were salvaged. There were no false negatives or positives with either monitoring modality. Two ViOptix probes failed after 4 and 3.5 days of use, respectively. No LD probes failed during use. Unlike ViOptix, the LD probes are sterilizable. Of the 6 LD probes purchased, the average sterilization cycle per probe was 11, and only 1 broke after 14 cycles. Cost per flap for this LD probe was $154. Cost of each ViOptix probe (disposable) was $1,000. Average number of recorded entries per flap was 92 for LDF and 88 for ViOptix. Flaps were monitored for 3-6 days and every hour for the first 2-5 days, then every 2 or 4 hours. For LDF, mean perfusion value was 32.43 with SD of 15.65 (coefficient of variation [CV], 38.1). Mean ViOptix reading was 63.9% with SD of 6.26 (CV, 10.6). Final LDF values (last 8 hours recorded, mean) increased an average of 118% compared to the beginning (initial 8 hours, mean), whereas ViOptix dropped by −7.5% (average).
CONCLUSION:
LDF and NIRS are equally efficacious in free flap monitoring. Cost associated with LD recyclable probes is significantly less than the single-use Vi-Optix probes. Periflux LDF recordings tend to increase significantly with time (more than double), whereas that of ViOptix drops slightly by the end of each monitoring session. Perfusion data from LDF have much greater CV (38.1 versus 10.6) compared to ViOptix. NIRS produces more steady numbers throughout the monitoring period (less fluctuations) compared to LDF for uncomplicated flaps.
